VERU INC. Deferred Income Tax Liabilities, Net
VERU INC. (VERU) had Deferred Income Tax Liabilities, Net of $63.43 thousand as of 2022-12-31, per its 10-Q filed 2023-02-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2024-04-01
- 2022-12-31: Deferred Income Tax Liabilities, Net $63.43K.
- 2022-09-30: Deferred Income Tax Liabilities, Net $81.07K.
- 2022-06-30: Deferred Income Tax Liabilities, Net $63.43K.
- 2022-03-31: Deferred Income Tax Liabilities, Net $63.43K.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2022-12-31 | $63.43K 10-Q · filed 2023-02-09 |
| 2022-09-30 | $81.07K 10-K/A · filed 2024-04-01 |
| 2022-06-30 | $63.43K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $63.43K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $63.43K 10-Q · filed 2022-02-09 |
| 2021-09-30 | $63.43K 10-K · filed 2022-12-05 |
| 2021-06-30 | $74.72K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $74.72K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $74.72K 10-Q · filed 2021-02-10 |
| 2020-09-30 | $74.72K 10-K · filed 2021-12-02 |
| 2020-06-30 | $292.74K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $296.61K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $296.61K 10-Q · filed 2020-02-12 |
| 2019-09-30 | $296.61K 10-K · filed 2020-12-10 |
| 2018-09-30 | $844.76K 10-K · filed 2019-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |